...
npce-img

Neuropace Inc, Common Stock

NPCE

NMQ

$11.03

+$0.12

(1.1%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$330.72M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
56.35K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.80
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.45 L
$18.15 H
$11.03

About Neuropace Inc, Common Stock

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameNPCESectorS&P500
1-Week Return-2.22%-2.27%-0.57%
1-Month Return20.55%-3.96%1.21%
3-Month Return48.45%-9.7%7.57%
6-Month Return65.12%-3.37%11.45%
1-Year Return34.35%3.71%28.48%
3-Year Return12.44%3.8%29.52%
5-Year Return-55.81%39.78%90.66%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue36.97M41.14M45.18M45.52M65.42M[{"date":"2019-12-31","value":56.51,"profit":true},{"date":"2020-12-31","value":62.88,"profit":true},{"date":"2021-12-31","value":69.06,"profit":true},{"date":"2022-12-31","value":69.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue10.51M10.87M11.75M13.03M17.30M[{"date":"2019-12-31","value":60.74,"profit":true},{"date":"2020-12-31","value":62.81,"profit":true},{"date":"2021-12-31","value":67.91,"profit":true},{"date":"2022-12-31","value":75.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit26.46M30.27M33.44M32.49M48.12M[{"date":"2019-12-31","value":54.99,"profit":true},{"date":"2020-12-31","value":62.91,"profit":true},{"date":"2021-12-31","value":69.48,"profit":true},{"date":"2022-12-31","value":67.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin71.58%73.59%74.00%71.38%73.56%[{"date":"2019-12-31","value":96.73,"profit":true},{"date":"2020-12-31","value":99.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.46,"profit":true},{"date":"2023-12-31","value":99.4,"profit":true}]
Operating Expenses48.49M43.32M57.17M73.29M75.30M[{"date":"2019-12-31","value":64.41,"profit":true},{"date":"2020-12-31","value":57.54,"profit":true},{"date":"2021-12-31","value":75.93,"profit":true},{"date":"2022-12-31","value":97.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(22.03M)(13.05M)(23.74M)(40.79M)(27.17M)[{"date":"2019-12-31","value":-2203100000,"profit":false},{"date":"2020-12-31","value":-1305100000,"profit":false},{"date":"2021-12-31","value":-2373700000,"profit":false},{"date":"2022-12-31","value":-4079400000,"profit":false},{"date":"2023-12-31","value":-2717400000,"profit":false}]
Total Non-Operating Income/Expense(17.17M)(22.67M)(19.30M)(12.24M)(11.25M)[{"date":"2019-12-31","value":-1716600000,"profit":false},{"date":"2020-12-31","value":-2267200000,"profit":false},{"date":"2021-12-31","value":-1930500000,"profit":false},{"date":"2022-12-31","value":-1223900000,"profit":false},{"date":"2023-12-31","value":-1124900000,"profit":false}]
Pre-Tax Income(29.97M)(24.28M)(36.08M)(47.08M)(32.96M)[{"date":"2019-12-31","value":-2997300000,"profit":false},{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false}]
Income Taxes10.77M11.70M2.03M6.29M1.44M[{"date":"2019-12-31","value":91.99,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":17.34,"profit":true},{"date":"2022-12-31","value":53.73,"profit":true},{"date":"2023-12-31","value":12.28,"profit":true}]
Income After Taxes(40.74M)(35.98M)(38.11M)(53.37M)(34.39M)[{"date":"2019-12-31","value":-4074000000,"profit":false},{"date":"2020-12-31","value":-3598200000,"profit":false},{"date":"2021-12-31","value":-3810900000,"profit":false},{"date":"2022-12-31","value":-5337000000,"profit":false},{"date":"2023-12-31","value":-3439310500,"profit":false}]
Income From Continuous Operations(29.97M)(24.28M)(36.08M)(47.08M)(32.96M)[{"date":"2019-12-31","value":-2997300000,"profit":false},{"date":"2020-12-31","value":-2427800000,"profit":false},{"date":"2021-12-31","value":-3608000000,"profit":false},{"date":"2022-12-31","value":-4708200000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(40.74M)(35.98M)(38.11M)(53.37M)(32.96M)[{"date":"2019-12-31","value":-4074000000,"profit":false},{"date":"2020-12-31","value":-3598200000,"profit":false},{"date":"2021-12-31","value":-3810900000,"profit":false},{"date":"2022-12-31","value":-5337000000,"profit":false},{"date":"2023-12-31","value":-3295600000,"profit":false}]
EPS (Diluted)-(0.17)(33.99)(1.92)(1.28)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-17,"profit":false},{"date":"2021-12-31","value":-3399,"profit":false},{"date":"2022-12-31","value":-192,"profit":false},{"date":"2023-12-31","value":-128,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NPCE
Cash Ratio 3.84
Current Ratio 5.59
Quick Ratio 4.77

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NPCE
ROA (LTM) -14.74%
ROE (LTM) -214.55%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NPCE
Debt Ratio Lower is generally better. Negative is bad. 0.90
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.10

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NPCE
Trailing PE NM
Forward PE NM
P/S (TTM) 4.31
P/B 33.52
Price/FCF NM
EV/R 4.52
EV/Ebitda NM

FAQs

What is Neuropace Inc share price today?

Neuropace Inc (NPCE) share price today is $11.03

Can Indians buy Neuropace Inc shares?

Yes, Indians can buy shares of Neuropace Inc (NPCE) on Vested. To buy Neuropace Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NPCE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Neuropace Inc be purchased?

Yes, you can purchase fractional shares of Neuropace Inc (NPCE) via the Vested app. You can start investing in Neuropace Inc (NPCE) with a minimum investment of $1.

How to invest in Neuropace Inc shares from India?

You can invest in shares of Neuropace Inc (NPCE) via Vested in three simple steps:

  • Click on Sign Up or Invest in NPCE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Neuropace Inc shares
What is Neuropace Inc 52-week high and low stock price?

The 52-week high price of Neuropace Inc (NPCE) is $18.15. The 52-week low price of Neuropace Inc (NPCE) is $5.45.

What is Neuropace Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Neuropace Inc (NPCE) is

What is Neuropace Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Neuropace Inc (NPCE) is 33.52

What is Neuropace Inc dividend yield?

The dividend yield of Neuropace Inc (NPCE) is 0.00%

What is the Market Cap of Neuropace Inc?

The market capitalization of Neuropace Inc (NPCE) is $330.72M

What is Neuropace Inc’s stock symbol?

The stock symbol (or ticker) of Neuropace Inc is NPCE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top